Lung Cancer News

Most cancer clinical trials use inaccurate tests to evaluate kidney function when determining participant eligibility, according to results of a cross-sectional study.

BOSTON — Completing a CT scan and ordering lung cancer screening occurred more frequently if eligible patients received a digital health program intervention vs. enhanced usual care, according to data presented at the CHEST Annual Meeting.

Inpatient management of people with cancer varied considerably based on their housing status, according to results of a cross-sectional study.

The FDA expanded the approval of nivolumab for treatment of non-small cell lung cancer.

The FDA has granted 510(k) clearance to qCT LN Quant, an AI solution that aids clinicians in finding lung nodule diameters, malignancy risk and management approaches, according to a manufacturer-issued press release.

In this episode of Meeting Mic, we bring you pearls and perspectives from the 2024 World Conference on Lung Cancer, as well as Healio’s top headlines from the meeting.

A randomized phase 2 trial of individuals with cancer cachexia showed those assigned ponsegromab gained significantly more weight than those assigned placebo.

Older adults undergoing cancer treatment exhibited reduced risk for falling if they had discussions about physical activity with their health care provider, according to study results.

The FDA approved osimertinib for treatment of certain patients with locally advanced or unresectable non-small cell lung cancer.

Older cancer survivors exhibited increased risk for cardiovascular disease than cancer-free individuals of the same age, according to a secondary analysis of a randomized study.